Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Packham

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2018
Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia PatientsSamantha Drennan, Giorgia Chiodin, Annalisa D'Avola, et al.
Cellular Signalling|May 21, 2022
BTK-independent regulation of calcium signalling downstream of the B-cell receptor in malignant B-cellsRachael Arthur, Alexander Wathen, Elizabeth A Lemm, et al.
Blood|December 14, 2011
Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemiaAlex Paterson, C Ian Mockridge, Jemimah E Adams, et al.
Blood|January 12, 2012
The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cellsFrancesco Forconi, Kathleen N Potter, Elisa Sozzi, et al.
Journal of Medicinal Chemistry|October 26, 2007
The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitorAlexander Yurek-George, Alexander Richard Liam Cecil, Alex Hon Kit Mo, et al.
Chembiochem : a European Journal of Chemical Biology|December 14, 2004
The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortinSean M Davidson, Paul A Townsend, Chris Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinomaThomas Armstrong, Graham Packham, Lindsay B Murphy, et al.
Blood Advances|August 8, 2018
CD40L/IL-4-stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATMLarissa Lezina, Ruth V Spriggs, Daniel Beck, et al.
Blood|March 6, 2013
Targeting B-cell anergy in chronic lymphocytic leukemiaBenedetta Apollonio, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, et al.
Cellular and Molecular Life Sciences : CMLS|August 16, 2021
Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cellsSarah Wilmore, Karly-Rai Rogers-Broadway, Joe Taylor, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2018
Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia PatientsSamantha Drennan, Giorgia Chiodin, Annalisa D'Avola, et al.
Cellular Signalling|May 21, 2022
BTK-independent regulation of calcium signalling downstream of the B-cell receptor in malignant B-cellsRachael Arthur, Alexander Wathen, Elizabeth A Lemm, et al.
Blood|December 14, 2011
Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemiaAlex Paterson, C Ian Mockridge, Jemimah E Adams, et al.
Blood|January 12, 2012
The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cellsFrancesco Forconi, Kathleen N Potter, Elisa Sozzi, et al.
Journal of Medicinal Chemistry|October 26, 2007
The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitorAlexander Yurek-George, Alexander Richard Liam Cecil, Alex Hon Kit Mo, et al.
Chembiochem : a European Journal of Chemical Biology|December 14, 2004
The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortinSean M Davidson, Paul A Townsend, Chris Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinomaThomas Armstrong, Graham Packham, Lindsay B Murphy, et al.
Blood Advances|August 8, 2018
CD40L/IL-4-stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATMLarissa Lezina, Ruth V Spriggs, Daniel Beck, et al.
Blood|March 6, 2013
Targeting B-cell anergy in chronic lymphocytic leukemiaBenedetta Apollonio, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, et al.
Cellular and Molecular Life Sciences : CMLS|August 16, 2021
Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cellsSarah Wilmore, Karly-Rai Rogers-Broadway, Joe Taylor, et al.
Pageof 13